Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 238,876
  • Shares Outstanding, K 14,646
  • Annual Sales, $ 166,660 K
  • Annual Income, $ -82,670 K
  • EBIT $ -35 M
  • EBITDA $ 42 M
  • 60-Month Beta 0.89
  • Price/Sales 1.43
  • Price/Cash Flow 3.32
  • Price/Book 1.33

Options Overview Details

View History
  • Implied Volatility 72.15% ( -41.71%)
  • Historical Volatility 25.18%
  • IV Percentile 98%
  • IV Rank 57.11%
  • IV High 113.86% on 12/18/24
  • IV Low 16.62% on 05/21/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 79
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 986
  • Open Int (30-Day) 721

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.11
  • Number of Estimates 1
  • High Estimate -0.11
  • Low Estimate -0.11
  • Prior Year 0.05
  • Growth Rate Est. (year over year) -320.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.82 +3.06%
on 12/18/24
18.18 -10.29%
on 12/12/24
-0.87 (-5.06%)
since 11/20/24
3-Month
15.82 +3.06%
on 12/18/24
25.65 -36.41%
on 10/11/24
-9.19 (-36.04%)
since 09/20/24
52-Week
15.82 +3.06%
on 12/18/24
29.11 -43.98%
on 07/18/24
-5.96 (-26.76%)
since 12/20/23

Most Recent Stories

More News
Anika Therapeutics Management to Present at Upcoming Investment Conferences in December 2024

Anika Therapeutics announces participation in investment conferences, showcasing management and discussing orthopedic advancements.Quiver AI SummaryAnika Therapeutics, Inc. has announced that its senior...

ANIK : 16.31 (-0.12%)
Anika To Participate in December 2024 Investor Conferences

ANIK : 16.31 (-0.12%)
New Strong Sell Stocks for November 11th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:A-Mark Precious Metals, Inc. AMRK is a precious metals trading company. The Zacks Consensus Estimate for its current year earnings...

ANIK : 16.31 (-0.12%)
AMRK : 25.79 (-1.00%)
ALG : 188.34 (-3.17%)
Anika: Q3 Earnings Snapshot

Anika: Q3 Earnings Snapshot

ANIK : 16.31 (-0.12%)
Anika Reports Third Quarter 2024 Financial Results

ANIK : 16.31 (-0.12%)
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

ANIK : 16.31 (-0.12%)
Anika Announces Third Quarter 2024 Results Conference Call Date

ANIK : 16.31 (-0.12%)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ANIK : 16.31 (-0.12%)
Anika: Q2 Earnings Snapshot

Anika: Q2 Earnings Snapshot

ANIK : 16.31 (-0.12%)
Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal®, Monovisc®, and Orthovisc®

/CNW/ - Pendopharm, a division of Pharmascience Canada ("Pendopharm"), is pleased to announce the renewal of its exclusive distribution agreement with Anika...

ANIK : 16.31 (-0.12%)

Business Summary

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative...

See More

Key Turning Points

3rd Resistance Point 17.98
2nd Resistance Point 17.51
1st Resistance Point 16.91
Last Price 16.31
1st Support Level 15.84
2nd Support Level 15.36
3rd Support Level 14.76

See More

52-Week High 29.11
Fibonacci 61.8% 24.04
Fibonacci 50% 22.47
Fibonacci 38.2% 20.90
Last Price 16.31
52-Week Low 15.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar